{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:44:25Z","timestamp":1788813865910,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03547-7","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T22:02:17Z","timestamp":1730325737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Mahmut","family":"Muslumanoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran","family":"Mollavelioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Cabioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selman","family":"Emiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Tukenmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Karanl\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolga","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravza","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Gunoz","family":"Comert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semen","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu Has","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Oflas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamuran","family":"Ibis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Ayd\u0131ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahit","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Igci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"issue":"4","key":"3547_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F, Gatti G. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595\u2013600.","journal-title":"Ann Surg"},{"issue":"8","key":"3547_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567\u201375.","journal-title":"N Engl J Med"},{"issue":"10","key":"3547_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"9","key":"3547_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599\u2013609.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"3547_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"12","key":"3547_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomized, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3547_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","volume":"16","author":"WJ Gradishar","year":"2018","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP. Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(3):310\u201320.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3547_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1245\/s10434-017-6263-y","volume":"25","author":"Z Al-Hilli","year":"2018","unstructured":"Al-Hilli Z, Hoskin TL, Day CN, Habermann EB, Boughey JC. Impact of neoadjuvant chemotherapy on nodal disease and nodal surgery by tumor subtype. Ann Surg Oncol. 2018;25:482\u201393.","journal-title":"Ann Surg Oncol"},{"key":"3547_CR9","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","volume":"25","author":"TT Nguyen","year":"2018","unstructured":"Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC. Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25:2596\u2013602.","journal-title":"Ann Surg Oncol"},{"key":"3547_CR10","unstructured":"Dwyer, Mary. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines \u00ae ) Breast Cancer NCCN.org NCCN Guidelines for Patients \u00ae available at http:\/\/www.nccn.org\/patients. 2023; Available from: https:\/\/www.nccn."},{"issue":"3","key":"3547_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s13193-019-00924-7","volume":"10","author":"SK Panda","year":"2019","unstructured":"Panda SK, Goel A, Nayak V, Shaik Basha S, Pande PK, Kumar K. Can preoperative ultrasonography and MRI replace sentinel lymph node biopsy in management of axilla in early breast cancer\u2014a prospective study from a tertiary cancer center. Indian J Surg Oncol. 2019;10(3):483\u20138.","journal-title":"Indian J Surg Oncol"},{"issue":"11","key":"3547_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.acra.2013.08.003","volume":"20","author":"H Abe","year":"2013","unstructured":"Abe H, Schacht D, Kulkarni K, Shimauchi A, Yamaguchi K, Sennett CA, Jiang Y. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound. Acad Radiol. 2013;20(11):1399\u2013404.","journal-title":"Acad Radiol"},{"issue":"4","key":"3547_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton T, Hunt KK. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg. 2014;260(4):608.","journal-title":"Ann Surg"},{"issue":"10","key":"3547_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3547_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK. Identification and resection of the clipped node decreases the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0\u2013T4, N1\u20132) who receive neoadjuvant chemotherapy\u2013results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802.","journal-title":"Ann Surg"},{"issue":"14","key":"3547_CR16","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA"},{"issue":"7","key":"3547_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schmatloch S. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3547_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3547_CR19","doi-asserted-by":"publisher","first-page":"e1251","DOI":"10.1016\/j.clbc.2018.08.002","volume":"18","author":"M Yan","year":"2018","unstructured":"Yan M, Abdi MA, Falkson C. Axillary management in breast cancer patients: a comprehensive review of the key trials. Clin Breast Cancer. 2018;18(6):e1251\u20139.","journal-title":"Clin Breast Cancer"},{"issue":"67","key":"3547_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.breast.2022.12.010","volume":"1","author":"V Galimberti","year":"2023","unstructured":"Galimberti V, Fontana SK, Vicini E, Morigi C, Sargenti M, Corso G, Magnoni F, Intra M, Veronesi P. This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients. Breast. 2023;1(67):21\u20135.","journal-title":"Breast"},{"key":"3547_CR21","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1245\/s10434-020-09211-0","volume":"28","author":"SM Wong","year":"2021","unstructured":"Wong SM, Basik M, Florianova L, Margolese R, Dumitra S, Muanza T, Carbonneau A, Ferrario C, Boileau JF. Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2021;28:2621\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"3547_CR22","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","volume":"7","author":"AV Barrio","year":"2021","unstructured":"Barrio AV, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D, Cody HS, El-Tamer M, Gemignani ML, Heerdt A, Kirstein L. Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy\u2014a rare event. JAMA Oncol. 2021;7(12):1851\u20135.","journal-title":"JAMA Oncol"},{"key":"3547_CR23","doi-asserted-by":"publisher","unstructured":"Bartels, S. A. L., Donker, M., Poncet, C., Sauv\u00e9, N., Straver, M. E., van de Velde, C. J. H., Mansel, R. E., Blanken, C., Orzalesi, L., Klinkenbijl, J. H. G., van der Mijle, H. C. J., Nieuwenhuijzen, G. A. P., Veltkamp, S. C., van Dalen, T., Marinelli, A., Rijna, H., Snoj, M., Bundred, N. J., Merkus, J. W. S., Belkacemi, Y., \u2026 Rutgers, E. J. T. (2023). Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981\u201322023 AMAROS Trial. J Clin Oncol. 2023;\u00a041(12), 2159\u20132165. https:\/\/doi.org\/10.1200\/JCO.22.01565","DOI":"10.1200\/JCO.22.01565"},{"key":"3547_CR24","doi-asserted-by":"crossref","unstructured":"Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Costantino JP, Curran Jr WJ, Wolmark N. NRG Oncology\/NSABP B-51\/RTOG 1304: A phase III clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC). [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res. 2016;76(4 Suppl):Abstract nr OT2-02-02.","DOI":"10.1158\/1538-7445.SABCS15-OT2-02-02"},{"key":"3547_CR25","unstructured":"Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy | ClinicalTrials.gov. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01901094."},{"key":"3547_CR26","doi-asserted-by":"publisher","unstructured":"Mailhot Vega R, Deladisma AM, Mobley EM, Wang S, Morris CG, Oladeru OT, Brooks E, Gharia BM, Spiguel LR, MacDonald SM, et al. Axillary Surgery Efficacy for Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy on NSABP B40 and B41.\u00a0J Clin Oncol.\u00a02023;41:524. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.524.","DOI":"10.1200\/JCO.2023.41.16_suppl.524"},{"issue":"1","key":"3547_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","volume":"193","author":"AA van Loevezijn","year":"2022","unstructured":"van Loevezijn AA, van der Noordaa ME, Stokkel MP, van Werkhoven ED, Groen EJ, Loo CE, Elkhuizen PH, Sonke GS, Russell NS, van Duijnhoven FH, Vrancken Peeters MJ. Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol. Breast Cancer Res Treat. 2022;193(1):37\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"3547_CR28","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1245\/s10434-020-08928-2","volume":"28","author":"MF Almahariq","year":"2021","unstructured":"Almahariq MF, Levitin R, Quinn TJ, Chen PY, Dekhne N, Kiran S, Desai A, Benitez P, Jawad MS, Gustafson GS, Dilworth JT. Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual N1 nodal disease following neoadjuvant chemotherapy. Ann Surg Oncol. 2021;28:930\u201340.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3547_CR29","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.ejso.2021.06.024","volume":"47","author":"N Cab\u0131o\u011flu","year":"2021","unstructured":"Cab\u0131o\u011flu N, Karanl\u0131k H, Y\u0131ld\u0131r\u0131m N, M\u00fcsl\u00fcmano\u011flu M, Karadeniz G\u00c7, Can DT, T\u00fckenmez M, Ersoy YE, Uras C, Zengel B, Emiro\u011flu S. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study. Eur J Surg Oncol. 2021;47(10):2506\u201314.","journal-title":"Eur J Surg Oncol"},{"key":"3547_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1245\/s10434-020-09073-6","volume":"28","author":"O Kantor","year":"2021","unstructured":"Kantor O, Wakeman M, Weiss A, Wong S, Laws A, Grossmith S, Mittendorf EA, King TA. Axillary management after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. Ann Surg Oncol. 2021;28:1358\u201367.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3547_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-017-4405-3","volume":"166","author":"M Ahmed","year":"2017","unstructured":"Ahmed M, Jozsa F, Baker R, Rubio IT, Benson J, Douek M. Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients. Breast Cancer Res Treat. 2017;166(2):329\u201336. https:\/\/doi.org\/10.1007\/s10549-017-4405-3. Epub 2017 Jul 28. Erratum in: Breast Cancer Res Treat. 2017;166(2):337. PMID: 28755147; PMCID: PMC5668351.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3547_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190014","volume":"293","author":"R Kim","year":"2019","unstructured":"Kim R, Chang JM, Lee HB, Lee SH, Kim SY, Kim ES, Cho N, Moon WK. Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer. Radiology. 2019;293(1):49\u201357. https:\/\/doi.org\/10.1148\/radiol.2019190014. Epub 2019 Aug 13 PMID: 31407967.","journal-title":"Radiology"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03547-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03547-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03547-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T22:03:08Z","timestamp":1730325788000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03547-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3547"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03547-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4712847\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of Istanbul University, Istanbul Faculty of Medicine (08.08.2023\u20131981986), by the ethical standards of the institutional and national research committee, and with the 1964 Helsinki Declaration. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have approved the publication of the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}